1. home
  2. > covid-19
  3. > Pfizer's Covid-19 vaccine 95% effective: final study result
replay trump newslist
up NEXT IN 5 SECONDS sports newslist
tap to unmute
00:00/00:00
NaN/0

Pfizer's Covid-19 vaccine 95% effective: final study result

Nov 18, 2020 19:03 IST

The coronavirus vaccine developed by Pfizer has shown 95 per cent efficacy in the late-stage trial, the company said on Wednesday. The drugmaker said the efficacy of the vaccine developed with German partner BioNTech was consistent across age and ethnicity demographics, and that there were no major side effects, a sign that the immunization could be employed broadly around the world. Efficacy in adults over 65 years, who are at particular risk from the virus, was over 94 per cent. The pharmaceutical giant said that it plans to apply for emergency US authorisation within days.

Covid-19